Biomerica, Inc.
BMRA · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $8,259 | $29,613 | $100,674 | $53,419 |
| - Cash | $3,053 | $2,399 | $3,058 | $2,372 |
| + Debt | $373 | $458 | $543 | $626 |
| Enterprise Value | $5,579 | $27,672 | $98,159 | $51,673 |
| Revenue | $1,380 | $749 | $1,119 | $1,636 |
| % Growth | 84.2% | -33.1% | -31.6% | – |
| Gross Profit | $424 | -$244 | $19 | $437 |
| % Margin | 30.7% | -32.6% | 1.7% | 26.7% |
| EBITDA | $107 | -$1,460 | -$1,111 | -$993 |
| % Margin | 7.8% | -194.9% | -99.3% | -60.7% |
| Net Income | $2 | -$1,544 | -$1,163 | -$950 |
| % Margin | 0.1% | -206.1% | -103.9% | -58.1% |
| EPS Diluted | 0.003 | -0.16 | -0.068 | -0.056 |
| % Growth | 101.9% | -135.6% | -22.3% | – |
| Operating Cash Flow | -$268 | -$661 | -$1,045 | -$791 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$268 | -$661 | -$1,045 | -$791 |